Meet the 2016 Laureate Award Winners: Steven Grinspoon, MD

Grinspoon, Steven

Gerald D. Aurbach Award for Outstanding Translational Research
Steven Grinspoon, MD
Massachusetts General Hospital

Steven Grinspoon, MD, is the Endocrine Society’s selection for the 2016 Gerald D. Aurbach Award for Outstanding Translational Research. After graduating from Cornell University, Dr. Grinspoon attended the University of Rochester School of Medicine and completed his residency in internal medicine at Columbia-Presbyterian Hospital. He then did an endocrinology fellowship at Massachusetts General Hospital (MGH), focusing on neuroendocrinology with his mentor Anne Klibanski. Dr. Grinspoon is currently professor of medicine at Harvard Medical School and director, Program in Nutritional Metabolism at MGH.

Dr. Grinspoon’s long-standing focus has been to understand the neuroendocrine regulation of body composition in HIV, with a focus on how it relates to the growth hormone (GH) axis. His work in HIV lipodystrophy started with a clinical finding. In his clinic, Dr. Grinspoon was impressed with altered fat distribution in several patients with HIV infection. Further investigation led to the seminal work in characterizing lipodystrophy in such patients. He hypothesized that augmentation of GH pulse amplitude with GHRH would reduce visceral fat and improve metabolic abnormalities in HIV lipodystrophy. His work led the FDA to approve Tesamorelin for HIV lipodystrophy in 2010. In follow-up studies, he has shown that Tesamorelin significantly reduces hepatic fat by 40% as assessed by spectroscopy among HIV-infected patients with lipodystrophy. Indeed, the use of Tesamorelin is the first strategy shown to reduce hepatic fat in the HIV population.

These studies demonstrate Dr. Grinspoon’s ability to take a finding from bedside to bench, and back to bedside. In addition to his clinical research successes, he has been an active educator and mentor in clinical investigation; he has mentored over 25 trainees who have gone on to academic careers, the majority of whom are actively involved in clinical investigation. This demonstrates Steve’s dedication to training and mentorship.




You may also like

  • Endocrine Society Urges Congress to Increase Funding for NIH

    Funding needed by start of new fiscal year to advance public health during pandemic The Endocrine Society is calling on Congress to pass the House Labor-HHS spending bill to ensure health agencies are funded before the start of Fiscal Year 2021 and to avoid the tumult and disruption of a continuing resolution and potential government shutdowns. The…

  • Individuals Taking Class of Steroid Medications at High Risk for COVID-19

    JCEM Editors examine pandemic’s impact on endocrine patients in editorial Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according…